ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2020
[Preliminary Recommendations for Lung Surgery during 2019 Novel Coronavirus Disease (COVID-19) Epidemic Period].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.Bioorganic chemistry · 2021Pooled it
- Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.Critical reviews in oncology/hematology · 2020Pooled it
- Surgical Practice in the Current COVID-19 Pandemic: A Rapid Systematic Review.Clinics (Sao Paulo, Brazil) · 2020Pooled it
- COVID-19 After Lung Resection in Northern Italy.Seminars in thoracic and cardiovascular surgery · 2022Article
- Global health emergencies during the pandemic and their solutionsTurkish journal of medical sciences · 2021Review
- Managing Lung Cancer during Coronavirus Disease 2019 Pandemic.Turkish thoracic journal · 2021Review
- Dealing with lung cancer in the COVID-19 scenario (A review).Molecular and clinical oncology · 2021Review
- A narrative review of invasive diagnostics and treatment of early lung cancer.Translational lung cancer research · 2021Review
- COVID-19 Pandemic and the Global Perspective of Turkish Thoracic Society.Turkish thoracic journal · 2020Review
- Aerosol-generating procedures in thoracic surgery in the COVID-19 era in Malaysia.Asian cardiovascular & thoracic annals · 2020Article
- The successful management of Thirty-six hepatopancreatobiliary surgeries under the intensive protective arrangements during the COVID-19 pandemic.Acta bio-medica : Atenei Parmensis · 2020Article
- Lung Cancer Management in COVID-19 Pandemic.Turkish thoracic journal · 2020Review
- A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.European journal of cancer (Oxford, England : 1990) · 2020Review
- Commentary: The double responsibility of the thoracic surgeon at the time of the pandemic: A perspective from the North of Italy.The Journal of thoracic and cardiovascular surgery · 2020Article
- Global guidance for surgical care during the COVID-19 pandemic.The British journal of surgery · 2020Review
- COVID-19 among medical personnel in the operating room.Infection control and hospital epidemiology · 2020Article
- When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.Japanese journal of clinical oncology · 2020Article
- To Do or Not to Do?-A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic.Indian journal of surgical oncology · 2020Review
- Preliminary recommendations for lung surgery during COVID-19 epidemic period.Thoracic cancer · 2020Article
- Protease Inhibitor Use in COVID-19.SN comprehensive clinical medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In December 2019, China diagnosed the first patient with 2019 novel coronavirus disease (COVID-19), and the following development of the epidemic had a huge impact on China and the whole world. For patients with lung occupying lesions, the whole process of diagnosis and treatment can not be carried out as usual due to the epidemic. For thoracic surgeons, the timing of surgical intervention should be very carefully considered. All thoracic surgeons in China should work together to develop the proper procedures for the diagnosis and treatment in this special situation, and continuously update the recommendations based on epidemic changes and further understanding of COVID-19. Here, we only offer some preliminary suggestions based on our own knowledge for further reference and discussion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.